Stephen W. Ranere > Latham & Watkins LLP > Boston, United States > Lawyer Profile
Latham & Watkins LLP Offices

200 CLARENDON STREET
BOSTON MA 02116
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Stephen W. Ranere

Position
Stephen Ranere represents technology and life sciences companies, from startup through IPO and beyond. Steve also advises venture capital and private equity firms involved in the technology, life sciences, and other growth industries.
Steve leverages extensive experience to help clients in a broad range of sectors — including fintech, climate tech, digital health, and AI-enabled drug discovery — navigate:
- Early-stage formation and strategy
- Venture capital and growth equity financings
- Mergers and acquisitions
- Public offerings of securities
- Public company representation
- Corporate governance matters
He marshals the resources across Latham’s robust global platform to craft solutions for clients at any stage of corporate development.
A recognized leader within the firm, Steve serves on the Digital Health Task Force and was previously on the firm’s Associates Committee.
He maintains an active pro bono practice, including participating in legal workshops for small-business owners in underserved communities.
Lawyer Rankings
United States > M&A/corporate and commercial > Venture capital and emerging companies
Favored for its ability to utilize its premier technology and life sciences offerings, Latham & Watkins LLP’s emerging companies and venture capital practice acts for an array of start-ups and growth companies on formations through to funding and exit transactions. The team also represents venture capital funds and other financial institutions on investment and exit strategies. In Silicon Valley, emerging companies chair Benjamin Potter is the key contact for a raft of start-up technology, fintech, healthcare, and life sciences clients; he recently advised Eigen Labs on its $100m Series B financing. Rounding out the lead partners are global department vice chairs Brian Patterson, who sits in San Francisco, and Haim Zaltzman, who splits his time between New York, San Francisco and Silicon Valley. In Century City, Alex Voxman is equipped to advise emerging companies and venture capital funds on the full suite of corporate, M&A, and financing matters, while in Boston Stephen Ranere specializes in venture capital and corporate transactions in the technology and life sciences sectors. Also in Boston, John Chory
handles both company formations and subsequent IPOs. The group was boosted in 2024 by the hire of three new partners in San Francisco: duo Seth Gottlieb and Alex Kassai joined from Cooley LLP, while Zachary Fallon joined from technology-focused firm, Ketsal.
Lawyer Rankings
Top Tier Firm Rankings
- Insurance > Advice to policyholders
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Cartel
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending
- Finance > Commercial lending: Advice to bank lenders
- Intellectual property > Copyright
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Healthcare > Life sciences
- Real estate > Land use/zoning
- Healthcare > Life sciences
- Healthcare > Life sciences
- Healthcare > Life sciences
- Healthcare > Life sciences
- Healthcare > Life sciences
- Intellectual property > Patents: licensing
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Antitrust > Merger control
- International trade and national security > National Security
- Healthcare > Life sciences
- Intellectual property > Patents: licensing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Industry focus > Sport
- Finance > Structured finance: derivatives and structured products
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- M&A/corporate and commercial > Corporate governance
- International trade and national security > Customs, export controls and economic sanctions
- Industry focus > Education
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Government > Government contracts
- Insurance > Insurance: non-contentious
- Dispute resolution > International litigation
- Dispute resolution > Leading trial lawyers
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Financial services litigation
- Healthcare > Health insurers
- Media, technology and telecoms > Outsourcing
- Healthcare > Service providers
- Dispute resolution > International arbitration
- Dispute resolution > Leading trial lawyers
- Intellectual property > Trademarks: litigation
- Dispute resolution > Leading trial lawyers
- Finance > Financial services regulation
- Finance > Commercial lending > Advice to direct lenders/private credit
- Dispute resolution > Corporate investigations and white-collar criminal defense